Sichenzia Ross Ference Carmel LLP Represents INmune Bio Inc. in $9.7 Million Registered Direct Offering By Sichenzia Ross Ference LLP | April 29, 2024 INmune Bio Inc. $9,700,000 Registered Direct Offering April 2024 Read More
Sichenzia Ross Ference Carmel LLP Represents INmune Bio Inc. in $4.8 Million Registered Direct Offering By Sichenzia Ross Ference LLP | April 25, 2024 INmune Bio Inc. $4,800,000 Registered Direct Offering April 2024 Read More
Sichenzia Ross Ference LLP Represents mCloud Technologies Corp. in $25 Million Public Offering By Sichenzia Ross Ference LLP | December 29, 2022 mCloud Technologies Corp. $25,000,000 Series A Preferred Shares Warrants December 2022 Read More
Sichenzia Ross Ference LLP Represents A.G.P./Alliance Global Partners as Sole Placement Agent in $24M Registered Direct Offering of Alpine 4 Holdings, Inc. By Sichenzia Ross Ference LLP | November 29, 2021 Alpine 4 Holdings, Inc. $24,000,000 Common Stock and Warrants November 2021 Read More
Sichenzia Ross Ference LLP Represents Inmune Bio, Inc. in a $40.0 Million Registered Direct Offering By Sichenzia Ross Ference LLP | July 16, 2021 Inmune Bio, Inc. $40,000,000 Common Stock July 2021 Read More
Sichenzia Ross Ference LLP Represents Kaspien Holdings Inc. in $13.5 Million Bought Deal Offering of Common Stock By Sichenzia Ross Ference LLP | March 19, 2021 Kaspien Holdings Inc. $13,500,000 Common Stock Offering March 2021 Read More
Sichenzia Ross Ference LLP Represents A.G.P./ Alliance Global Partners as Placement Agent in $15M Registered Direct Offering of Arcimoto, Inc. By Sichenzia Ross Ference LLP | November 24, 2020 Arcimoto, Inc. $15,000,000 Common Stock Offering November 2020 Read More
Sichenzia Ross Ference LLP Represents INmune Bio, Inc. in $21.74 Million Public Offering of Common Stock By Sichenzia Ross Ference LLP | July 17, 2020 INmune Bio, Inc. $21,740,000 Common Stock July 2020 Read More
Sichenzia Ross Ference LLP Represents Relmada Therapeutics, Inc. in a $115 Million Underwritten Public Offering of Common Stock By Sichenzia Ross Ference LLP | May 8, 2020 Relmada Therapeutics $115,000,000 Common Stock December 2019 Read More
Sichenzia Ross Ference LLP Represents RealWear, Inc. in $80 Million Financing Transactions By Sichenzia Ross Ference LLP | May 7, 2020 RealWear, Inc. $80,000,000 Series B Financing July 2019 Read More